Inhibition of deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2

CORC > 合肥物质科学研究院 > 中国科学院合肥物质科学研究院 > 医学 > 专题未命名

	Inhibition of deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2
	Qi S(亓爽)
刊名	LEUKEMIA
	2021
语种	英语
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/125923]
专题	医学_专题未命名
作者单位	CHMFL-HCMTC Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui, 230031, PR China
推荐引用方式 GB/T 7714	Qi S. Inhibition of deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2[J]. LEUKEMIA,2021.
APA	Qi S.(2021).Inhibition of deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.LEUKEMIA.
MLA	Qi S."Inhibition of deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2".LEUKEMIA (2021).